Induction of tolerance to self-antigens using genetically modified bone marrow cells

By Alderuccio Frank   Toh Ban-Hock  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 7, 2004-07 ,pp. : 1007-1014

Informa Healthcare

Access to resources Recommend Favorite

Genetically Engineered Vaccines: An Overview

By dertzbaugh M.T.  

Plasmid, Vol. 39, Iss. 2, 1998-03 ,pp. : 100-113

Academic Press

Access to resources Recommend Favorite

T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance

By Phan G.Q.   Wang E.   Marincola F.M.  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 3, 2001-05 ,pp. : 511-523

Informa Healthcare

Access to resources Recommend Favorite

Genetically modified dendritic cells – a new, promising cancer treatment strategy?

By Wysocki PJ   Grabarczyk P   Mackiewicz-Wysocka M   Kowalczyk DW   Mackiewicz A  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 835-845

Informa Healthcare

Access to resources Recommend Favorite

Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?

By Shurin Michael R   Gregory Melissa   Morris John C   Malyguine Anatoli M  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 11, 2010-11 ,pp. : 1539-1553

Informa Healthcare

Access to resources Recommend Favorite